# Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage

> **NCT03371329** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 9 (actual)

## Conditions studied

- Hemorrhagic Stroke
- Intracerebral Hemorrhage

## Interventions

- **BIOLOGICAL:** MSC

## Key facts

- **NCT ID:** NCT03371329
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-12
- **Primary completion:** 2020-10-09
- **Final completion:** 2020-10-09
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03371329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03371329, "Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03371329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*